{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T22:19:00Z","timestamp":1696630740833},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T00:00:00Z","timestamp":1393027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00508-014-0508-6","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T10:35:34Z","timestamp":1392978934000},"page":"228-237","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 study"],"prefix":"10.1007","volume":"126","author":[{"given":"Denisa Janickova","family":"Zdarska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Kvapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Rusavy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Krcma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Broz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohumila","family":"Krivska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavla","family":"Kadlecova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,22]]},"reference":[{"issue":"3","key":"508_CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jdiacomp.2004.10.001","volume":"19","author":"IB Hirsch","year":"2005","unstructured":"Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19(3):178\u201381.","journal-title":"J Diabetes Complications"},{"issue":"3","key":"508_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1191\/1358863x05vm617oa","volume":"10","author":"P Danielson","year":"2005","unstructured":"Danielson P, Truedsson L, Eriksson KF, Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral disease with and without diabetes mellitus. Vasc Med. 2005;10(3):191\u20138.","journal-title":"Vasc Med"},{"issue":"4","key":"508_CR3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1067\/mlc.2003.27","volume":"141","author":"MP Cohen","year":"2003","unstructured":"Cohen MP, Shea E, Chen S, Shearman CW. Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. J Lab Clin Med. 2003;141(4):242\u20139.","journal-title":"J Lab Clin Med"},{"key":"508_CR4","unstructured":"Taguchi T, Brownlee M. \u2009The biochemical mechanisms of diabetic tissue damage. In: Pickup J, Williams G, editors. Textbook of diabetes. 3rd ed. Oxford: Blackwell Science; 2003."},{"key":"508_CR5","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","volume":"52","author":"L Qualiaro","year":"2003","unstructured":"Qualiaro L, Piconi L, Assalone R, Martinelli L, Motz E, Ceriello A. Intermitent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role o protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795\u2013804.","journal-title":"Diabetes"},{"issue":"12","key":"508_CR6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s001250050617","volume":"39","author":"M Hanefeld","year":"1996","unstructured":"Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39(12):1577\u201383.","journal-title":"Diabetologia"},{"issue":"12","key":"508_CR7","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2337\/diabetes.49.12.2142","volume":"49","author":"M Lepore","year":"2000","unstructured":"Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000;49(12):2142\u20138.","journal-title":"Diabetes"},{"issue":"6","key":"508_CR8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.23.6.813","volume":"23","author":"D Owens","year":"2000","unstructured":"Owens D, Coates P, Luzio S, Tinbergen JP, Kurzhals R. Pharmacokinetics of 125I-labeled \u2009insulin glarginee (HOE 901) in healthy men. Diabetes Care. 2000;23(6):813\u20139.","journal-title":"Diabetes Care"},{"issue":"8","key":"508_CR9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/diacare.23.8.1130","volume":"23","author":"H Yki-J\u00e4rvinen","year":"2000","unstructured":"Yki-J\u00e4rvinen H, Dressler A, Zieman M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin combination therapy in type 2 diabetes. HOE 901\/3002 Study Group. Diabetes Care. 2000;23(8):1130\u20136.","journal-title":"Diabetes Care"},{"key":"508_CR10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2337\/dc07-2401","volume":"31","author":"B Kovatchev","year":"2008","unstructured":"Kovatchev B, Anderson S, Heinemann L, Willim C. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care. 2008;31:1160\u20134.","journal-title":"Diabetes Care"},{"key":"508_CR11","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"508_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2005.09.015","volume":"152","author":"C Stettler","year":"2006","unstructured":"Stettler C, Allemann S, J\u00fcni P, Cull CA, Holman RR, et al. Glycemic control and macrovascular disease in type 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006;152:27\u201338.","journal-title":"Am Heart J"},{"issue":"5","key":"508_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/dmrr.962","volume":"25","author":"L Monnier","year":"2009","unstructured":"Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorder of type 2 diabetes: a move towards a unified glucose tetrat concept. Diabetes Metab Res Rev. 2009;25(5):393\u2013402.","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"508_CR14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1464-5491.2010.03059.x","volume":"27","author":"S Buscemi","year":"2010","unstructured":"Buscemi S, Re A, Batsis JA, et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in type 2 diabetes. Diabet Med. 2010;27(8):872\u20138.","journal-title":"Diabet Med"},{"issue":"1","key":"508_CR15","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.hjr.0000368193.24732.66","volume":"17","author":"A Ceriello","year":"2010","unstructured":"Ceriello A. Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes. Eur J Cardiovasc Prev Rehabil. 2010;17(Suppl. 1):S15\u20139.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"508_CR16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/dmrr.865","volume":"24","author":"RJ Wright","year":"2008","unstructured":"Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008;24:353\u201363.","journal-title":"Diabetes Metab Res Rev"},{"key":"508_CR17","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316771","volume-title":"Statistical intervals: a guide for practitioners","author":"GJ Hahn","year":"1991","unstructured":"Hahn, GJ, Meeker WQ. Statistical intervals: a guide for practitioners. New York: John Wiley & Sons; 1991."}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-014-0508-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-014-0508-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-014-0508-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:58:48Z","timestamp":1559095128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-014-0508-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,22]]},"references-count":17,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1007\/s00508-014-0508-6","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,22]]}}}